000 | 01925 a2200541 4500 | ||
---|---|---|---|
005 | 20250516131916.0 | ||
264 | 0 | _c20140206 | |
008 | 201402s 0 0 eng d | ||
022 | _a1873-4847 | ||
024 | 7 |
_a10.1016/j.jnutbio.2012.11.009 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBerbée, Jimmy F P | |
245 | 0 | 0 |
_aResveratrol protects against atherosclerosis, but does not add to the antiatherogenic effect of atorvastatin, in APOE*3-Leiden.CETP mice. _h[electronic resource] |
260 |
_bThe Journal of nutritional biochemistry _cAug 2013 |
||
300 |
_a1423-30 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAtherosclerosis _xdrug therapy |
650 | 0 | 4 | _aAtorvastatin |
650 | 0 | 4 |
_aBiomarkers _xblood |
650 | 0 | 4 |
_aCholesterol, Dietary _xadministration & dosage |
650 | 0 | 4 |
_aCholesterol, LDL _xblood |
650 | 0 | 4 | _aDrug Synergism |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aHeptanoic Acids _xpharmacology |
650 | 0 | 4 |
_aHydroxymethylglutaryl-CoA Reductase Inhibitors _xpharmacology |
650 | 0 | 4 |
_aInflammation _xdrug therapy |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Transgenic |
650 | 0 | 4 |
_aOxidative Stress _xdrug effects |
650 | 0 | 4 |
_aPyrroles _xpharmacology |
650 | 0 | 4 | _aResveratrol |
650 | 0 | 4 |
_aStilbenes _xpharmacology |
700 | 1 | _aWong, Man C | |
700 | 1 | _aWang, Yanan | |
700 | 1 | _avan der Hoorn, José W A | |
700 | 1 | _aKhedoe, Padmini P S J | |
700 | 1 | _avan Klinken, Jan B | |
700 | 1 | _aMol, Isabel M | |
700 | 1 | _aHiemstra, Pieter S | |
700 | 1 | _aTsikas, Dimitrios | |
700 | 1 | _aRomijn, Johannes A | |
700 | 1 | _aHavekes, Louis M | |
700 | 1 | _aPrincen, Hans M G | |
700 | 1 | _aRensen, Patrick C N | |
773 | 0 |
_tThe Journal of nutritional biochemistry _gvol. 24 _gno. 8 _gp. 1423-30 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.jnutbio.2012.11.009 _zAvailable from publisher's website |
999 |
_c22436242 _d22436242 |